Clinical and Biological Characterization of Patients with Low/Intermediate-1 Risk Myelodysplastic Syndrome and Iron Overload

被引：0

作者：

Ivars, David ^{[1
]}

Collado, Rosa ^{[2
]}

Alguero, Carmen ^{[1
]}

Carmen Tormos, M. ^{[1
]}

Diaz, Laura ^{[1
]}

Luis Garcia-Ghnenez, Jose ^{[3
]}

Arrizabalaga, Beatriz ^{[4
]}

Orero, Mayte ^{[2
]}

Perez, Pedro ^{[2
]}

Sanchez, Magdalena ^{[2
]}

Angeles Ruiz, M. ^{[5
]}

Yaguee, Nuria ^{[5
]}

Sancho-Tello, Reyes ^{[6
]}

Regadera, Ana ^{[7
]}

Tormo, Mar ^{[8
]}

Egea, Mercedes ^{[2
]}

Vidal, Elena ^{[2
]}

Enrique O'Connor, J. ^{[1
]}

Saez, Guillermo T. ^{[1
]}

Carbonell, Felix ^{[2
]}

机构：

[1] Univ Valencia, Valencia, Spain

[2] Hosp Gen Univ Valencia, Biomed Diag Ctr, Hematol Serv, Valencia, Spain

[3] Biomed Network Res Ctr Rare Dis, CIBERER, Valencia, Spain

[4] Hosp Cruces, Baracaldo, Spain

[5] Hosp Francesc de Borja, Valencia, Spain

[6] Hosp Arnau Vilanova, Hematol Serv, Valencia, Spain

[7] Hosp Gen Requena, Hematol Serv, Valencia, Spain

[8] Hosp Clin, Valencia, Spain

来源：

BLOOD | 2012年 / 120卷 / 21期

关键词：

D O I：

10.1182/blood.V120.21.4956.4956

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

4956

引用

页数：2

共 50 条

[31] T cell mediated autologous cytotoxicity against hematopoietic precursor cells in low and intermediate-1 risk Myelodysplastic syndrome.
Chamuleau, Martine E. D.
Westers, Theresia M.
van Dreunen, Linda
Groenland, Judith
Zevenbergen, Adri
Eeltink, Corien
Ossenkoppele, Gert J.
de Loosdrecht, Arjan A. Van
BLOOD, 2007, 110 (11) : 223B - 223B
[32] LONG TERM FOLLOW UP OF 5 PATIENTS TREATED WITH MESENCHYMAL STROMAL CELL IMMUNOMODULATORY THERAPY FOR LOW AND INTERMEDIATE-1 IPSS RISK MYELODYSPLASTIC SYNDROME
Tan, D.
Carnley, B.
Sturm, M.
Cirillo, M.
CYTOTHERAPY, 2024, 26 (06) : S40 - S40
[33] Low-risk myelodysplastic syndromes and iron overload
Fenaux, Pierre
HEMATOLOGIE, 2006, 12 : 9 - 9
[34] IRON OVERLOAD AND TRANSIENT ELASTOGRAPHY IN PATIENTS WITH MYELODYSPLASTIC SYNDROME
Risum, M.
Barfod, T.
Raaschou-Jensen, K.
LEUKEMIA RESEARCH, 2015, 39 : S58 - S59
[35] Diagnostic procedures and treatment of patients with Myelodysplastic Syndromes (MDS) of low and intermediate-1 risk. Results of the outpatient MDS registry
Schmitz, S.
Boettger, I
Schnell, R.
Lerchenmueller, C.
Sauer, A.
Severin, K.
Germing, U.
Steinmetz, H. T.
ONKOLOGIE, 2012, 35 : 148 - 148
[36] Treatment of Anemia with Darbepoetin Alfa in Patients with Low and Intermediate-1 Risk Myelodysplastic Syndromes. Results from the ARAMYS Study
Villegas, Ana
Arrizabalaga, B.
Fernandez-lago, C.
Mouzo, M.
Mayans, Jr
Gonalez-Porras, Jr
Duarte, Rafael
Remacha, Angel Francisco
Luno, Elisa
Gasquet, J. A.
BLOOD, 2008, 112 (11) : 1184 - 1184
[37] Randomized Open-Label Phase II Study of Decitabine in Patients with Low- or Intermediate-1 Risk Myelodysplastic Syndromes
Garcia-Manero, Guillermo
Jabbour, Elias
Borthakur, Gautam
Faderl, Stefan
Estrov, Zeev
Godley, Lucy
Gabrail, Nashat Y.
Berdeja, Jesus G.
Nadeem, Ahmed
Stein, Karen
Noble, Yvonne
Kassalow, Laurent
Kantarjian, Hagop M.
BLOOD, 2011, 118 (21) : 1628 - 1629
[38] Improving clinical outcome in patients with myelodysplastic syndrome and iron overload using iron chelation therapy
Leitch, Heather A.
LEUKEMIA RESEARCH, 2007, 31 : S7 - S9
[39] Use of newer prognostic indices for patients with myelodysplastic syndromes in the low and intermediate-1 risk categories: a population-based study
Valcarcel, David
Sanz, Guillermo
Ortega, Margarita
Nomdedeu, Benet
Luno, Elisa
Diez-Campelo, Maria
Teresa Ardanaz, Maria
Pedro, Carmen
Montoro, Julia
Collado, Rosa
Andreu, Rafa
Marco, Victor
Teresa Cedena, Maria
de Paz, Raquel
Tormo, Mar
Xicoy, Blanca
Ramos, Fernando
Bargay, Joan
Gonzalez, Bernardo
Brunet, Salut
Antonio Munoz, Juan
Gomez, Valle
Bailen, Alicia
Sanchez, Joaquin
Merchan, Brayan
del Canizo, Consuelo
Vallespi, Teresa
LANCET HAEMATOLOGY, 2015, 2 (06): : E260 - E266
[40] Impact of iron overload and potential benefit from iron chelation in low-risk myelodysplastic syndrome
Shenoy, Niraj
Vallumsetla, Nishanth
Rachmilewitz, Eliezer
Verma, Amit
Ginzburg, Yelena
BLOOD, 2014, 124 (06) : 873 - 881

← 1 2 3 4 5 →